Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Recent progress of genome study for anaplastic thyroid cancer.

Lee J, Hwang JA, Lee EK.

Genomics Inform. 2013 Jun;11(2):68-75. doi: 10.5808/GI.2013.11.2.68. Epub 2013 Jun 30.

PMID:
23843772
[PubMed]
Free PMC Article
2.

Anaplastic thyroid cancer: prevalence, diagnosis and treatment.

Chiacchio S, Lorenzoni A, Boni G, Rubello D, Elisei R, Mariani G.

Minerva Endocrinol. 2008 Dec;33(4):341-57. Review.

PMID:
18923370
[PubMed - indexed for MEDLINE]
3.

Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.

Xing M.

Thyroid. 2010 Jul;20(7):697-706. doi: 10.1089/thy.2010.1646. Review.

PMID:
20578891
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.

Hou P, Liu D, Shan Y, Hu S, Studeman K, Condouris S, Wang Y, Trink A, El-Naggar AK, Tallini G, Vasko V, Xing M.

Clin Cancer Res. 2007 Feb 15;13(4):1161-70.

PMID:
17317825
[PubMed - indexed for MEDLINE]
Free Article
5.

Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.

Guerra A, Di Crescenzo V, Garzi A, Cinelli M, Carlomagno C, Tonacchera M, Zeppa P, Vitale M.

BMC Surg. 2013;13 Suppl 2:S44. doi: 10.1186/1471-2482-13-S2-S44. Epub 2013 Oct 8. Review.

PMID:
24267151
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.

Are C, Shaha AR.

Ann Surg Oncol. 2006 Apr;13(4):453-64. Epub 2006 Feb 15. Review.

PMID:
16474910
[PubMed - indexed for MEDLINE]
8.

Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.

Perri F, Lorenzo GD, Scarpati GD, Buonerba C.

World J Clin Oncol. 2011 Mar 10;2(3):150-7. doi: 10.5306/wjco.v2.i3.150.

PMID:
21611089
[PubMed]
Free PMC Article
9.

Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.

Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC.

J Oncol. 2011;2011:542358. doi: 10.1155/2011/542358. Epub 2011 Jun 12.

PMID:
21772843
[PubMed]
Free PMC Article
10.

Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma.

Komoike Y, Tamaki Y, Sakita I, Tomita N, Ohue M, Sekimoto M, Miyazaki M, Kadota M, Masuda N, Ooka M, Ohnishi T, Nakano Y, Kozaki T, Kobayashi T, Matsuura N, Ikeda T, Horii A, Monden M.

Int J Oncol. 1999 Jun;14(6):1157-62.

PMID:
10339673
[PubMed - indexed for MEDLINE]
11.

Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.

Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S.

World J Surg. 2012 Jun;36(6):1247-54. doi: 10.1007/s00268-012-1437-z.

PMID:
22311136
[PubMed - indexed for MEDLINE]
12.

Anaplastic Thyroid Cancer: a Retrospective analysis of 120 cases.

Aldehaim M, Mahmood R, Hussain F, Memon A, Al-Hebshi A, Al-Rajhi N, El-Sebaie M, Khalil E, Ahmad M.

Gulf J Oncolog. 2014 Jan;1(15):32-7.

PMID:
24610286
[PubMed - in process]
13.

American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.

Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM; American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce.

Thyroid. 2012 Nov;22(11):1104-39. doi: 10.1089/thy.2012.0302.

PMID:
23130564
[PubMed - indexed for MEDLINE]
14.

Poorly differentiated and anaplastic thyroid cancer.

Patel KN, Shaha AR.

Cancer Control. 2006 Apr;13(2):119-28. Review.

PMID:
16735986
[PubMed - indexed for MEDLINE]
Free Article
15.

Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization.

Miura D, Wada N, Chin K, Magrane GG, Wong M, Duh QY, Clark OH.

Thyroid. 2003 Mar;13(3):283-90.

PMID:
12729478
[PubMed - indexed for MEDLINE]
16.

Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth.

Onda M, Akaishi J, Asaka S, Okamoto J, Miyamoto S, Mizutani K, Yoshida A, Ito K, Emi M.

Br J Cancer. 2005 Jun 20;92(12):2216-24.

PMID:
15956966
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Thyroid cancer: emerging role for targeted therapies.

Sipos JA, Shah MH.

Ther Adv Med Oncol. 2010 Jan;2(1):3-16. doi: 10.1177/1758834009352667.

PMID:
21789122
[PubMed]
Free PMC Article
18.

Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.

Tseng LM, Huang PI, Chen YR, Chen YC, Chou YC, Chen YW, Chang YL, Hsu HS, Lan YT, Chen KH, Chi CW, Chiou SH, Yang DM, Lee CH.

J Pharmacol Exp Ther. 2012 May;341(2):410-23. doi: 10.1124/jpet.111.188730. Epub 2012 Feb 10.

PMID:
22328572
[PubMed - indexed for MEDLINE]
Free Article
19.

Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.

Kim KS, Min JK, Liang ZL, Lee K, Lee JU, Bae KH, Lee MH, Lee SE, Ryu MJ, Kim SJ, Kim YK, Choi MJ, Jo YS, Kim JM, Shong M.

Clin Cancer Res. 2012 Jun 1;18(11):3071-8. doi: 10.1158/1078-0432.CCR-11-2757. Epub 2012 Apr 3.

PMID:
22472175
[PubMed - indexed for MEDLINE]
Free Article
20.

Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.

Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN.

Clin Cancer Res. 2004 Dec 15;10(24):8594-602.

PMID:
15623643
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk